These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10372898)

  • 1. The role of botulinus toxin type A in treatment--with special reference to children.
    Gordon N
    Brain Dev; 1999 Apr; 21(3):147-51. PubMed ID: 10372898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of botulinum toxin in neurological indications.
    Ward AB; Molenaers G; Colosimo C; Berardelli A
    Eur J Neurol; 2006 Dec; 13 Suppl 4():20-6. PubMed ID: 17112346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin treatment in children].
    Sätilä H; Vähäsarja V; Paavilainen P
    Duodecim; 2011; 127(22):2417-24. PubMed ID: 22238919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin in children with cerebral palsy.
    Singhi P; Ray M
    Indian J Pediatr; 2004 Dec; 71(12):1087-91. PubMed ID: 15630317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin for the treatment of movement disorders.
    Kopanidis P; Das C
    Aust J Gen Pract; 2018 Sep; 47(9):598-601. PubMed ID: 30244558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of botulinum toxin in head and face medicine: an interdisciplinary field.
    Laskawi R
    Head Face Med; 2008 Mar; 4():5. PubMed ID: 18331633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other noncosmetic uses of BOTOX.
    Verheyden J; Blitzer A; Brin MF
    Semin Cutan Med Surg; 2001 Jun; 20(2):121-6. PubMed ID: 11474744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin treatment for horizontal strabismus in children with cerebral palsy].
    Cronemberger MF; Mendonça TS; Bicas HE
    Arq Bras Oftalmol; 2006; 69(4):523-9. PubMed ID: 17119725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of botulinum toxin in pediatric spasticity (cerebral palsy).
    Berweck S; Heinen F
    Mov Disord; 2004 Mar; 19 Suppl 8():S162-7. PubMed ID: 15027070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
    Barrett RS
    Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study.
    Schasfoort F; Dallmeijer A; Pangalila R; Catsman C; Stam H; Becher J; Steyerberg E; Polinder S; Bussmann J
    J Rehabil Med; 2018 Jan; 50(1):22-29. PubMed ID: 28949368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the motor cerebral palsy child with botulinum toxin A: mode of action, injection places in management].
    Carrelet P; Bollini G; Mancini J; Chabrol B
    Arch Pediatr; 2002 Sep; 9(9):928-33. PubMed ID: 12387176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum toxin type A in pediatric patients with cerebral palsy: a three-center retrospective chart review.
    Gormley ME; Gaebler-Spira D; Delgado MR
    J Child Neurol; 2001 Feb; 16(2):113-8. PubMed ID: 11292216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in the treatment of neurological disorders.
    Denislic M; Pirtosek Z; Vodusek DB; Zidar J; Meh D
    Ann N Y Acad Sci; 1994 Mar; 710():76-87. PubMed ID: 8154763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in the management of cerebral palsy.
    Jefferson RJ
    Dev Med Child Neurol; 2004 Jul; 46(7):491-9. PubMed ID: 15230464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.